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Michael S. Emery, MD,j for the ACC’s Sports and Exercise Council Leadership Group

ABSTRACT
The last few decades have seen substantial growth in the populations of competitive athletes and highly active
people (CAHAP). Although vigorous physical exercise is an effective way to reduce the risk of cardiovascular (CV)
disease, CAHAP remain susceptible to inherited and acquired CV disease, and may be most at risk for adverse
CV outcomes during intense physical activity. Traditionally, multidisciplinary teams comprising athletic trainers, physical
therapists, primary care sports medicine physicians, and orthopedic surgeons have provided clinical care for CAHAP.
However, there is increasing recognition that a care team including qualiﬁed CV specialists optimizes care delivery for
CAHAP. In recognition of the increasing demand for CV specialists competent in the care of CAHAP, the American College
of Cardiology has recently established a Sports and Exercise Council. An important primary objective of this council is
to deﬁne the essential skills necessary to practice effective sports cardiology. (J Am Coll Cardiol 2017;70:1902–18)
© 2017 Published by Elsevier on behalf of the American College of Cardiology Foundation.

C

ompetitive athletes and highly active people

relevant in clinical practice. People with occult CV

(CAHAP) are a growing population. Although

disease are susceptible to sudden cardiac death dur-

routine physical exercise is an effective way

ing exercise. However, sudden death prevention rep-

to reduce the risk of cardiovascular (CV) disease, it

resents only 1 element of caring for CAHAP. Accurate

does not confer complete immunity (1,2), and actually

interpretation of diagnostic testing with an emphasis

increases the risk of CV events acutely, even in

on

trained individuals (3). The complex interplay be-

exercise-induced adaptation, efﬁcient and targeted

tween CV disease and vigorous physical activity re-

assessment of symptoms, and provision of longitudi-

mains incompletely understood, but is increasingly

nal care including the development of exercise

differentiating

pathology

from

physiological
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recommendations following CV disease diagnosis are

These adaptations often manifest during

ABBREVIATIONS

all critical skills for the effective clinical care of

clinical evaluation and may be evident during

AND ACRONYMS

CAHAP.

physical examination and interpretation of

Multidisciplinary

diagnostic testing. Accurate interpretation of

trainers, physical therapists, primary care sports

clinical data derived during the assessment of

medicine physicians, and orthopedic surgeons have

CAHAP requires an understanding both of

traditionally provided clinical care for CAHAP, and

basic exercise physiology and the numerous

ASCVD = atherosclerotic

this team-based approach will continue to represent

adaptive CV changes that are common in this

cardiovascular disease

the standard of care. However, the optimal CAHAP

patient population. Essential knowledge base

CAHAP = competitive athletes

care team includes a dedicated CV specialist to pro-

and skill sets for the sports cardiologist per-

and highly active people

vide collaboration during pre-participation cardio-

taining to exercise physiology and exercise-

CV = cardiovascular

vascular disease screening (PPCS), evaluation and

induced

of

athletes

comprising

ACC = American College of

athletic

management

teams

with

suspected

and

conﬁrmed CV disease, and participation in the generation of policies designed to maximize safe sport
participation. The practice of sports cardiology is
growing at a rapid pace, yet currently, an ofﬁcial
competency statement such as those developed by
the Core Cardiovascular Training Statement and
endorsed by the American Board of Internal Medicine
for other CV subspecialties is lacking. This document
was written in response to this unfulﬁlled need. The
purpose of this paper is to highlight the basic fund of
knowledge and the corollary skills required for the
effective practice of sports cardiology. Although the
present document was not designed to serve as a
formal

education

curriculum

or

template

for

continuing medical education, it is anticipated that it
will set the stage for future discussions about how to
include sports cardiology into existing CV training
requirements and board certiﬁcation processes. This
document identiﬁes 4 fundamental clinical domains
of knowledge that are critical to the care of CAHAP
(Central Illustration). Each domain will be deﬁned,
and key skill sets and/or clinical approach algorithms
will be presented. Recommendations in this document are based on available evidence, and where
evidence is lacking, reﬂect expert opinion. Recommendations are presented in a Medical Knowledge and
Patient Care and Procedural Skills format to maintain
consistency with the American College of Cardiology’s (ACC’s) recent Lifelong Learning statement (4).
It is anticipated that this document will provide a
clinical framework for CV practitioners who participate in the care of CAHAP.

cardiac

remodeling

(EICR)

are

Association

ECG = 12-lead
electrocardiography

shown in Table 1.
FUNDAMENTAL

Cardiology

AHA = American Heart

CLINICAL

EXERCISE

PHYSIOLOGY. All forms of vigorous physical

EICR = exercise-induced
cardiac remodeling

ICD = implantable cardiac

activity and competitive athletics involve

deﬁbrillator

some combination of static and dynamic ex-

LV = left ventricular

ercise physiology (5). The terms static and

PPCS = pre-participation

dynamic refer to patterns of skeletal muscle

cardiovascular disease

activity and their consequent changes in CV
structure and function. Static activity is

screening

RV = right ventricular

characterized by short and forceful skeletal muscle
contractions, which can be quantiﬁed as an estimated
percentage of maximal voluntary contraction for
involved muscle groups. During bouts of relatively
pure static/strength activities, such as power weight
lifting and track and ﬁeld throwing events, intense
skeletal muscle activation coupled with stimulation
of mechanical and metabolic afferent signals lead to
acute increases in systemic vascular resistance and
arterial blood pressure. The primary role of the CV
system during acute bouts of static activity is to
maintain cardiac output in the face of increased left
ventricular (LV) afterload. This is accomplished by
increasing myocardial contractility, which facilitates
preservation of end-diastolic and -systolic LV volume. In contrast, dynamic/endurance activities are
characterized by repetitive, often rhythmic contraction and relaxation of large skeletal muscle groups,
which require increases in oxidative metabolism. The
intensity of dynamic activity can thus be quantiﬁed
_ 2 ). The primary
by measurement of oxygen uptake ( VO
CV response to dynamic activity is to increase cardiac
output to ensure adequate delivery of metabolic
substrate to active muscle beds. The magnitude of

EXERCISE-INDUCED CARDIAC REMODELING

cardiac output augmentation is tightly regulated by

VERSUS CV PATHOLOGY

energetic signals in skeletal muscle, is proportional to
the intensity of the dynamic activity, and is accom-

Moderate- to high-intensity physical activity, either

plished by increases in heart rate, augmentation of

for recreational exercise or competitive athletics, re-

stroke volume, and reductions in systemic vascular

quires an adaptive and healthy CV system. The CV

resistance. Diseases of the CV system that impair the

system adapts to repetitive bouts of exercise through

ability to maintain cardiac output in the face of

a complex series of structural and functional changes.

increased LV afterload and/or to increase cardiac
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C E N T R A L IL L U ST R A T I O N Overview of Fundamental Core Competencies in Sports Cardiology

Differentiation of EICR
from CV Pathology

Evaluation of the
Symptomatic CAHAP

Comprehensive Sports Cardiology

Management of the
CAHAP with CV Disease

Collaborative
Preparticipation CV
Screening

Baggish, A.L. et al. J Am Coll Cardiol. 2017;70(15):1902–18.

The 4 principal competency domains underlying the growing and rapidly evolving specialty of sports cardiology. Each domain requires
integration of the fundamental principles of general and subspecialty clinical cardiovascular medicine with a knowledge base unique to the
population of competitive athletes and highly active people (CAHAP). CV ¼ cardiovascular; EICR ¼ exercise-induced cardiac remodeling.

output in response to dynamic physiology often

epigenetic factors including sporting discipline and

manifest as symptoms including chest pain, inap-

duration of exercise exposure. In a landmark report,

propriate exertional dyspnea, and subjective exercise

athletes participating in sports with predominantly

intolerance.

dynamic physiology (swimmers and runners) were
found to have larger LV chamber diameters than ath-

EXERCISE-INDUCED CARDIAC REMODELING. Repetitive

letes practicing wrestling, a sport with a predomi-

participation in vigorous physical exercise stimulates

nantly static physiology (6). Although the notion that

adaptive changes in CV structure and function. This

EICR varies as a function of sport physiology has been

process, referred to as EICR, varies considerably across

challenged (7), this concept has been veriﬁed by

athletic populations and individual athletes based on a

numerous investigators (8–10). Recent reports extend

number of factors, including but not limited to

the scope of sport-speciﬁc EICR beyond LV structure to

ethnicity, sex, genetics (underlying genome), and

include LV diastolic function (11), right ventricular
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(RV) morphology (12), and atrial structure (13,14),
which respond to the principal stresses of static and

T A B L E 1 Exercise Physiology and Exercise-Induced Cardiovascular Remodeling:

Essential Skills for the Sports Cardiologist

dynamic exercise in variable ways.
Medical Knowledge

Dichotomization of sporting disciplines into either
static

or

dynamic

activity

is,

however,

overly

simplistic. Contemporary classiﬁcations of exercise
physiology acknowledge that most sporting disci-

Know the fundamental hemodynamic characteristics of static exercise.
Know the fundamental hemodynamic characteristics of dynamic exercise.
Know the current ACC/AHA classiﬁcation of sports.

plines involve some element of both static and dy-

Know the basic structural and functional patterns of cardiovascular adaptation that accompany
different forms of exercise.

namic stress (5), and that corollary EICR should

Know factors that may contribute to variability of EICR.

reﬂect the relative contributions of each cardinal

Know the rationale for the use of athlete-speciﬁc ECG interpretation criteria.

form of hemodynamic stress (Figure 1A). For example,
endurance sports all require the ability to markedly
augment cardiac output (dynamic stress) but involve
variable amounts of concomitant static stress. A
recent study evaluating rowers and runners documented increases in LV volume in both groups of
athletes, but thickening of LV walls only among
rowers due to the pulsatile pressure challenge
inherent in this sport (15). In sum, the biventricular

Know benign/adaptive ECG patterns that are considered “common and training-related.”
Know ECG patterns that are not related to exercise training and are potentially reﬂective of true
underlying disease.
Know deﬁnitions of the key geometric left ventricular hypertrophy variants encountered during
noninvasive imaging of CAHAP.
Know which geometric left ventricular hypertrophy variants typically associate with which
speciﬁc forms of exercise.
Know the expected response of the right ventricle, right atrium, and left atrium in response to
activities with dynamic physiology (endurance sports).
Know that resting biventricular systolic function, as assessed by ejection fraction, may be at or
slightly below the lower limits of normal under resting conditions among CAHAP with dilated
ventricles.

physiology sports leads to chamber dilation, whereas

Know that resting diastolic function should be normal to supranormal, as assessed
echocardiographically using complementary indexes (i.e., transmitral Doppler, tissue Doppler
imaging, and so on) among endurance-trained CAHAP.

the pressure challenge inherent in static sports leads

Know the differential diagnosis for left ventricular chamber dilation among CAHAP.

to LV wall thickening with minimal effects on the

Know the differential diagnosis for right ventricular chamber dilation among CAHAP.

other 3 cardiac chambers. Cardiac morphology among

Know the differential diagnosis for left ventricular wall thickening among CAHAP.

CAHAP may be also driven by comorbid factors, with

Know the rationale for prescribed detraining including relevant areas of physiological
uncertainty in clinical practice.

and biatrial volume challenge inherent in dynamic

recent studies of American style football lineman

Patient Care and Procedural Skills

demonstrating evidence of hypertensive LV hypertrophy (16) and subclinical systolic dysfunction (17).
DIAGNOSTIC

FINDINGS

IN

ATHLETES:

12-LEAD

ELECTROCARDIOGRAPHY. CV adaptations to exercise

commonly manifest on the 12-lead electrocardiography
(ECG)

and

may

overlap

with

patterns

reﬂecting

underlying CV disease. Criteria for ECG interpretation in
athletes were ﬁrst proposed in an expert consensus

Skill to comprehensively evaluate physical activity and exercise patterns, including type,
duration, and intensity of training and competition, to determine expected patterns of
underlying EICR.
Skill to apply contemporary ECG interpretation criteria for CAHAP in varied clinical settings
ranging from traditional clinic encounters to “in the ﬁeld” pre-participation screening.
Skill to interpret transthoracic echocardiographic data, in partnership with cardiovascular
imaging experts, among CAHAP with emphasis on recognition of imaging data consistent
with adaptive exercise-induced remodeling.
Skill to prescribe physiological deconditioning in selected cases where multimodality diagnostic
assessment fails to resolve “gray-zone” ﬁndings among CAHAP.

statement by the European Society of Cardiology (ESC)
in 2005 (18), and have undergone numerous revisions
(19–21). These revisions have reduced but not eliminated

ACC ¼ American College of Cardiology; AHA ¼ American Heart Association; CAHAP ¼ competitive athletes and
highly active people; ECG ¼ 12-lead electrocardiography; EICR ¼ exercise-induced cardiac remodeling.

the ECG’s propensity to generate false positive ﬁndings
(22–26). Contemporary athlete ECG criteria divide ﬁnd-

eccentric or concentric LV geometry. Eccentric LV

ings into benign, adaptive patterns, including sinus

hypertrophy, a balanced increase in wall thickness

bradycardia,

QRS

and chamber size, occurs most commonly among

voltage, and incomplete right bundle branch, and pat-

CAHAP who engage in sports with a combination of

terns that carry signiﬁcant associations with CV pathol-

high dynamic and high static physiology. Physiolog-

ogy (27). To date, no ECG interpretation criteria have

ical dilation of the RV (30) and both atrial chambers

been correlated with deﬁnitive clinical outcomes, and

(13,14,31) often accompanies eccentric LV remodeling.

large clinical trials, appropriately powered for relevant

In contrast, mild concentric hypertrophy, increased

outcomes, are lacking.

wall thickness with normal or even slightly reduced

DIAGNOSTIC FINDINGS IN ATHLETES: NONINVASIVE

chamber size (8,9), may develop among CAHAP who

IMAGING. EICR commonly results in thickening of

participate in high static/low-to-moderate dynamic

the LV walls and dilation of the LV chamber. LV

physiology sports, particularly when coupled with

hypertrophy, deﬁned by wall thicknesses in the range

resting hypertension (16). EICR is most commonly

of 11 to 13 mm, is common among CAHAP (28,29).

associated with preserved LV systolic function as

Athletes with LV hypertrophy demonstrate either

assessed

early

repolarization,

prominent

by

ejection

fraction

(32),

and

newer
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F I G U R E 1 The Interplay Between Exercise Physiology and EICR

I. Low (<10%)

II. Moderate (10-20%)

III. High (>30%)

A

Increasing Static Component

Bobsledding/Luge
Field events (throwing)
Gymnastics*†
Martial arts
Rock climbing
Sailing
Water skiing*†
Weight lifting*†
Windsurfing*†

Body building*†
Downhill skiing
Skateboarding*†
Snow boarding*†
Wrestling*

Boxing
Canoeing
Kayaking
Cycling*†
Decathlon
Rowing
Speed skating
Triathlon*†

Archery
Auto racing*†
Diving*†
Equestrian*†
Motorcycling*†

American football*
Field events (jumping)
Figure skating
Rodeoing*†
Rugby
Running (sprint)
Surfing
Synchronized swimming†
“Ultra” racing

Basketball*
Ice hockey*
Cross-country skiing
(skating technique)
Lacrosse*
Running (middle distance)
Swimming
Team handball
Tennis

Bowling
Cricket
Curling
Golf
Riflery
Yoga

Baseball/Softball
Fencing
Table tennis
Volleyball

Badminton
Cross-country skiing
(classic technique)
Field hockey*
Orienteering
Race walking
Racquetball/Squash
Running (long distance)
Soccer*

A. Low(<50%)

C. High(>75%)

B. Moderate(50-75%)

Increasing Dynamic Component

Increasing Static Component

High

B
Concentric LVH

Eccentric LVH &
RV Dilation

Eccentric LV Remodeling &
RV Dilation
Normal Morphology

Low

1906

Low

Increasing Dynamic Component

High

(A) Physiological classiﬁcation of common sporting disciplines representing relative contributions of static and dynamic physiology (reprinted
with permission from Levine et al. [5]), and (B) the anticipated structural cardiac adaptations that develop as a function of these underlying
physiological stressors. *Danger of bodily collision. †Increased risk if syncope occurs. EICR ¼ exercise-induced cardiac remodeling; LV ¼ left
ventricular; LVH ¼ left ventricular hypertrophy; RV ¼ right ventricular.
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F I G U R E 2 Approach to “Gray Zone” Cardiac Finding Among CAHAP

Thick LV Walls

Key Differential Diagnosis
Hypertrophic CMP
Hypertensive heart disease
Infiltrative heart disease
Valvular heart disease

Clinical Factors c/w EICR
High static sport background
No subjective symptoms
Benign family history

Imaging Findings c/w EICR
Mild symmetric LVH (walls <15 mm)
Normal RV dimensions
Normal/mildly enlarged LA
Normal aortic & mitral valves

Key Differential Diagnosis
Idiopathic dilated CMP
Toxic (ETH, drugs) CMP
Acute/Chronic myocarditis
Nutritional deficiency
CMP 2° tachyarrhythmia
Valvular heart disease

Clinical Factors c/w EICR
High dynamic sport background
No subjective symptoms
Benign family history
No history of prior illness
No history substance abuse

Imaging Findings c/w EICR
Concomitant RV dilation
+/- Mild LV wall thickening
Normal/low normal systolic function
Supra-normal LV diastolic indices
Normal/mildly enlarged LA & RA
Normal aortic & mitral valves

Key Differential Diagnosis
Arrhythmogenic RV CMP
Toxic (ETH, drugs) CMP
1° or 2° pulmonary HTN
Congenital heart disease
Valvular heart disease

Clinical Factors c/w EICR
High dynamic sport background
No subjective symptoms
Benign family history

Imaging Findings c/w EICR
Concomitant LV dilation
Normal RV morphology
Normal/low normal systolic function
Supra-normal LV diastolic indices
Normal/mildly enlarged LA & RA
Normal RV systolic pressure
Normal tricuspid and pulmonic valves

Dilated LV Chamber

Dilated RV Chamber

Common cardiac ﬁndings encountered during noninvasive imaging of competitive athletes and highly active people (CAHAP) include thickened LV walls, dilated LV
chambers, and dilated RV chambers. The determination of whether these ﬁndings represent benign EICR or myocardial pathology unrelated to exercise requires
consideration of a focused differential diagnosis coupled with an understanding of expected sport-speciﬁc patterns of physiological cardiac remodeling and integration
of key metrics derived from clinical assessment and noninvasive imaging. CMP ¼ cardiomyopathy; c/w ¼ consistent with; ETH ¼ ethanol; HTN ¼ hypertension;
LA ¼ left atrium; RA ¼ right atrium; other abbreviations as in Figure 1.

complementary indexes of systolic function (33).

clinical implications and represents 1 of the most

However, healthy athletes with physiological LV

fundamental sports cardiology skills. This process

dilation may demonstrate resting LV ejection fractions

requires the clinician to deﬁne an expected adaptive

at or slightly below the lower limits of normal (34), as

remodeling pattern after consideration of sport

it is stroke volume, not ejection fraction, that is

discipline (Figure 1B), and to consider key modifying

regulated by resting metabolic demands. LV diastolic

factors

function in CAHAP should be normal or enhanced, and

intensity of exercise exposure.

any evidence of diastolic dysfunction should raise a
high index of suspicion for pathology (35).

including

sex,

ethnicity,

and

duration/

EICR leads to 3 distinct gray zone ﬁndings, each
with a speciﬁc set of differential diagnoses (Figure 2).

Quantitative overlap between physiological hy-

EICR-induced LV and RV dilation may yield chamber

pertrophy and dilation with mild forms of heart

dimensions that approximate those found in overt

muscle disease has traditionally been referred to as

forms of disease, and thus, chamber dimension size

the “gray zone” (36). First described as an LV phe-

cut points are of limited value. Physiological LV and

nomenon, this concept now extends to the RV, as

RV dilation are typically accompanied by concomitant

both enlarge in response to endurance-based exercise

enlargement of the other ventricle, bi-atrial dilation,

training (37). Accurate diagnostic assessment of ath-

and normal to low-normal resting systolic function

letes with gray zone cardiac ﬁndings has important

that augments during exercise. Isolated LV or RV
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The use of prescribed detraining is based on the

T A B L E 2 Clinical Assessment of Symptomatic CAHAP: Essential Skills for

notion that EICR will regress following stimulus

the Sports Cardiologist

removal,
Medical Knowledge

whereas

hypertrophy

and/or

dilation

attributable to disease will not. Although “physio-

Know the differential diagnosis, including cardiovascular and noncardiovascular causes, of chest
pain in CAHAP.

logical myocardial atrophy” occurs during bed rest at

Know common atypical presentations of exertional ischemic chest pain associated with
atherosclerotic coronary artery disease among CAHAP.

rigorously tested in CAHAP. These limited data sug-

a rate of w1%/week (39), this principle has not been

Know common atypical presentations of exertional ischemic chest pain associated with
congenital coronary anomalies among CAHAP.

gest that EICR does appear to be a dynamic pheno-

Know how to optimize conventional approaches to exercise testing by avoiding test termination
at “diagnostic thresholds” and the inclusion of noninvasive imaging to maximize diagnostic
utility among CAHAP.
Know how and when to further customize exercise testing for CAHAP including the use of
individualized exercise protocols that permit manipulation of variables, such as exercise
intensity, duration, modality, and climate.

type

characterized

by

substantial

reversibility

(40–42), but the time course and magnitude of this
process remain uncertain. Furthermore, there are
currently no data deﬁning the effect of exercise
abstinence among patients with established car-

Know how and when to extend conventional exercise testing approaches to include adjunct
testing such as metabolic gas exchange, pulse oximetry, direct measurement of cardiac
output, and invasive hemodynamic measurements.

diomyopathic conditions. Until such critical areas of

Know common causes of collapse, including syncopal and nonsyncopal etiologies, during
exercise.

should be used cautiously and with an understanding

uncertainty

are

resolved,

prescribed

detraining

and acknowledgment of its inherent limitations.

Know common presentations of nonsyncope causes of collapse during exercise.
Know how to ascertain a comprehensive medical history of exercise-associated syncope with
emphasis on identifying features of both neurally mediated and alternative “high-risk” causes
of syncope.

EVALUATION OF SYMPTOMATIC CAHAP

Know the physiology responsible for post-exertional neurally mediated syncope.

Sports cardiologists must be capable of evaluating

Know common causes of palpitations among CAHAP.

CAHAP that present with symptoms suggestive of

Know clinical features suggestive of benign versus higher-risk causes of palpitations among
CAHAP.

underlying CV disease. This process requires integration of basic principles of general cardiology and

Know the cardiovascular and noncardiovascular causes of impaired exercise capacity or
decrements in exercise performance among CAHAP.

exercise physiology, with a comprehensive understanding of issues unique to this population including

Patient Care and Procedural Skills

Skill to perform a comprehensive personal and family medical history, including characterization
of exercise and physical activity habits (training, competition, and deconditioning) and the use
to performance-enhancing agents during the evaluation of symptomatic CAHAP.
Skill to determine the appropriate evaluation of CAHAP presenting with chest pain during or
unrelated to exercise.
Skill to oversee conventional assessments of exercise testing including the use of continuous ECG
and standard forms of noninvasive imaging.
Skill to develop and implement customized approaches to exercise testing with an emphasis on
reproducing the physiological conditions required to reproduce presenting symptoms among
individual CAHAP.
Skill to determine the appropriate evaluation of CAHAP presenting with collapse during or
unrelated to exercise to include selection of diagnostic imaging and ambulatory rhythm
monitoring.

atypical presentations of disease. The following sections address common chief complaints among
CAHAP and the essential knowledge base and skill
sets required for comprehensive assessment (Table 2).
CHEST PAIN. Chest pain, both at rest and during

exercise, is a common reason for CAHAP to seek
medical attention. Noncardiac causes for chest pain,
including gastrointestinal, pulmonary, and musculoskeletal processes, are common across CAHAP of all
ages and account for the vast majority of diagnoses

Skill to determine the appropriate evaluation of CAHAP presenting with palpitations during or
unrelated to exercise to include selection of diagnostic imaging and ambulatory rhythm
monitoring.

(43). Among young CAHAP (age <35 years), underlying

Skill to engage a collaborative and often multidisciplinary approach during the assessment of the
CAHAP with impaired exercise capacity or decrements in exercise performance.

chest pain, but when present, is often attributable to

Abbreviations as in Table 1.

trophic

CV disease accounts for the vast minority (w6%) of
potentially life-threatening diseases including hypercardiomyopathy,

anomalous

coronary

arteries, and congenital valvular disease. CAHAP
with congenital coronary anomalies often present with
dilation with any structural or functional abnormal-

atypical patterns, including exertional breathlessness

ities should be considered pathology until otherwise

in the absence of chest pain, a complaint that is often

proven. LV wall thickening among athletes is typi-

misdiagnosed as drug-refractory “exertional asthma,”

cally

rarely

or sporadic chest discomfort that is intermittently

exceeding 13 to 15 mm; values in excess of 15 mm

present at only very high exercise intensity. In

necessitate an individualized, often multimodality

contrast,

evaluation for explanatory cardiomyopathy.

(ASCVD) predominates as a cardiac cause for exer-

of

mild

to

moderate

magnitude,

atherosclerotic

cardiovascular

disease

Prescribed exercise detraining coupled with serial

tional chest pain in CAHAP >35 years of age. CAHAP

noninvasive imaging has been proposed as a diag-

with ASCVD may present with typical angina, but often

nostic option among CAHAP with gray zone hyper-

only experience a variant knows as “warm-up angina”:

trophy and an inconclusive initial assessment (38).

chest discomfort that occurs during the ﬁrst few
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minutes of exercise and then abates with continued

cardiac syncope, neurally mediated syncope, or

effort (44). This presentation is common among older

seizure typically experience a period of complete

athletes, a population in which no level of ﬁtness is

unconsciousness. Patients with cerebral hypoxia due

completely protective against ASCVD, and should raise

to cardiac arrest often have myoclonic jerking that

a high index of suspicion for disease. In CAHAP of all

can be confused with seizure activity and frequently

ages,

chest

experience incontinence. Seizures of neurological

discomfort, including palpitations, near-syncope or

origin may occur at times other than exercise and

syncope, or decline in exercise performance should

convulsions often precede loss of consciousness.

symptoms

accompanying

exertional

prompt a high index of suspicion for CV disease.

Syncope is deﬁned as a transient loss of con-

Evaluation of chest discomfort in CAHAP begins

sciousness and postural tone resulting from global

with a detailed patient history including ascertain-

cerebral hypoperfusion with spontaneous and com-

ment of familial disease patterns (genetic cardiomy-

plete recovery and no neurological sequelae (47).

opathies and premature ASCVD) and the use of illicit

Syncope in young CAHAP is most commonly neurally

drugs or performance-enhancing agents. Additional

mediated, but may be caused by alternative, poten-

diagnostic steps include resting ECG, measurement of

tially life threatening conditions including transient

a lipid proﬁle, and comprehensive exercise testing

tachyarrhythmias, bradyarrhythmias, and LV outﬂow

according to contemporary guidelines (45). Exercise

obstruction (48). Neurally mediated syncope is com-

testing in CAHAP should not be terminated at a pre-

mon in the immediate post-exercise period and during

deﬁned target heart rate but rather continued to

times unrelated to exercise, but is extremely rare

maximal volitional exercise capacity. This approach

during exertion. Neurally mediated syncope is typi-

permits characterization of the CV response to exer-

cally preceded by premonitory symptoms including a

cise across the entire intensity spectrum, thereby

generalized feeling of warmth, ﬂushing, and light-

maximizing the likelihood of symptom reproduction,

headedness culminating in a loss of consciousness.

which is necessary to exclude or conﬁrm underlying

Affected CAHAP often lower themselves to the ground

pathology. Conventional exercise protocols may

or fall slowly due to the relatively gradual onset of

not be sufﬁcient to reproduce chest discomfort in

symptoms rendering bodily injury uncommon. The

CAHAP, and customized testing designed to simulate

ensuing period of unconsciousness is typically brief

conditions under which symptoms develop is often

with minimal residual confusion in the absence of

required.

consider

concomitant hypoglycemia, which may affect CAHAP

manipulation of variables including exercise in-

with insulin-dependent diabetes, but is often followed

tensity, duration, modality, and climate. Cycle and

by persistent vagal symptoms including ﬂushing,

rowing ergometers are often required to optimally

warmth, fatigue, and nausea. In contrast, syncope

simulate training and competitive environments, and

caused by an acute arrhythmia is typically character-

standard treadmills present in most hospitals and

ized by an abrupt loss of consciousness followed by

practices may facilitate adequate sprint intervals in

dramatic collapse and injury (34).

Test

customization

should

elite athletes. Thus, comprehensive exercise assess-

The diagnostic evaluation of syncope begins with

ment in CAHAP may be best accomplished in referral

careful acquisition of medical history and when

centers that house advanced exercise testing labora-

available, review of video capture of the event, with

tory with staff trained in the art of individualizing

an emphasis on deﬁning the circumstances and sub-

exercise protocols. The inclusion of adjunct testing,

jective recall of the event. In situations where the

including metabolic gas exchange, pulse oximetry,

history is nondiagnostic, ECG and noninvasive car-

cardiac imaging, measurement of cardiac output, and

diac imaging are useful adjuncts that should be used

assessment of invasive hemodynamic parameters,

to

may improve the diagnostic yield of exercise testing

myocardial disease. Exercise testing designed to

and should be considered on a case-by-case basis.

trigger culprit arrhythmias and provocative testing to

SYNCOPE. Collapse during exercise due to alteration

bring out the ECG features of the long QT syndrome

or complete loss of consciousness is a medical emer-

(LQTS) may be warranted in selected individuals.

gency that requires immediate assessment (46).

Prolonged ambulatory monitoring, including the use

Causes of collapse include cardiac and neurally

of implantable loop recorders, should be considered

mediated syncope, heat stroke, hyponatremia, “ex-

for those with suspected arrhythmic syncope and an

ercise associated collapse,” and seizure. Victims of

initial nondiagnostic evaluation. It is imperative to

heat stroke, hyponatremia, and exercise-associated

capture a recording of cardiac rhythm during a

collapse typically retain some level of consciousness

syncopal event before excluding an arrhythmic cause

throughout their event. In contrast, athletes with

of syncope. Because relative orthostatic intolerance is

exclude

underlying

electrical,

valvular,

or
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characteristic of CAHAP and is a direct consequence

with objective evidence of declining capacity based on

of the cardiovascular adaptation (49,50), tilt-table

competition results or data derived from training ses-

testing should not be used to establish a diagnosis

sions. Exercise intolerance may occur in isolation or in

of neurally mediated syncope in this population as a

conjunction with other symptoms including dyspnea,

positive test is nonspeciﬁc.

chest pain, dizziness, palpitations, and generalized

PALPITATIONS. Palpitations, deﬁned as the sensa-

fatigue. Comprehensive evaluation of CAHAP with

tion of the heart beating too strong, too fast, or

exercise intolerance requires a collaborative approach

irregularly, are a symptom, not a diagnosis. During

that includes athletic trainers, coaches, internists,

times of excitement, fear, and psychological stress,

primary care sports medicine providers, and clinicians

palpitations typically reﬂect sinus tachycardia and

representing other medical subspecialties. The evalu-

are common among CAHAP due to their heightened

ation begins with a careful medical history focused

sense of body awareness. In contrast, palpitations

on exercise training routine, potential changes in

that occur in the absence of such triggers or during

lifestyle unrelated to exercise, prior performance

exercise are more likely to be caused by arrhythmias.

records, and data derived from wearable physiology

Palpitations characterized by sudden heart rate ac-

and ﬁtness monitors. Physical examination should

celeration or deceleration in the absence of an

assess for CV disease but also signs of alternative pa-

explanatory exercise pattern should raise the index of

thology including overtraining, autoimmune diseases,

suspicion of pathological arrhythmia. CAHAP pre-

iron deﬁciency, viral illnesses, asthma, laryngeal

senting with palpitations require evaluation to

dysfunction, and endocrine disorders. Subsequent

exclude possible life-threatening arrhythmias. Medi-

diagnostic testing should aim to exclude CV condi-

cal history is often unrevealing, but should be geared

tions, including chronotropic incompetence, reduced

to differentiating exertional palpitations from those

LV function, coronary artery disease, atrial ﬁbrillation,

unrelated to exercise and clariﬁcation of potentially

aortic stenosis, and HCM, followed by a broader

explanatory factors, including stimulant use, subop-

assessment aimed at other organ systems, systemic

timal sleep hygiene, and psychosocial stress. A

diseases, and psychiatric pathology including depres-

resting ECG should be performed to evaluate for pre-

sion and performance anxiety. Objective determina-

excitation, to check for disorders of repolarization

tion of exercise capacity, most accurately obtained by

including LQTS and Brugada syndrome, and to screen

measurement of peak oxygen consumption coupled to

for underlying structural heart disease. CAHAP that

some meaningful metric of external work (i.e., tread-

present with palpitations during exercise should un-

mill speed/incline, cycle ergometer power, and so on),

dergo exercise testing with adherence to the princi-

should be routine among athletes presenting with ex-

ples delineated in the previous text, and cardiac

ercise intolerance. These metrics can be compared to

imaging. When these initial diagnostic steps fail to

population-based or athlete-speciﬁc normative data

reproduce palpitations, ambulatory rhythm moni-

and used to assess both disease trajectory and

toring should be employed with a goal of rhythm

response to therapeutic intervention. Among athletes

capture during symptoms. There are numerous de-

older than age 35 years, normal aging is a consideration

vices designed to facilitate ambulatory rhythm

during differential diagnosis. However, it must be

detection, including conventional 24-h Holter moni-

emphasized that aging does not cause sudden declines

tors, wearable adhesive rhythm monitors, patient

in exercise capacity and should be considered a diag-

triggered devices designed to be used with smart

nosis of exclusion.

phone ECG, longer-term external loop monitors, and

MANAGEMENT OF CAHAP WITH
ESTABLISHED CV DIAGNOSES

long-term implantable monitors. Device selection
must be made on an individualized basis and may
involve the use of several devices in a sequential

Longitudinal care of CAHAP with established CV dis-

fashion until a diagnosis is secured (38). The evalua-

ease is among the most important responsibilities of

tion of CAHAP with palpitations often reveals benign

the sports cardiologist. In all cases, health and safety

but explanatory rhythm disturbances including pre-

should be prioritized over athletic goals, but in most

mature atrial and ventricular beats, which are best

cases, simultaneous attention to both outcomes facil-

addressed by counseling and reassurance and infre-

itates optimal care. Essential knowledge base and skill

quently, pharmacological suppression.

sets pertaining to the clinical management of CAHAP

IMPAIRED EXERCISE CAPACITY. CAHAP with exer-

with established CV disease are shown in Table 3.

cise intolerance present with subjective complaints,

COMPETITIVE SPORTS ELIGIBILITY CRITERIA. Compre-

often comparing themselves to more capable peers or

hensive recommendations for sport participation
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eligibility for competitive athletes with established CV
disease have been published (51). U.S.-based recommendations, ﬁrst proposed by the 36th Bethesda
Conference in 1985, have been updated approximately
every decade. These recommendations were designed
speciﬁcally for use among competitive athletes, a
group deﬁned by their participation in organized team
or individual sports that require regular competition,
place a high premium on excellence and achievement,
and require some form of systematic and usually
intense training. This invaluable resource represents
the starting point for all considerations about sport
participation following CV disease diagnosis. The most
recent update, cosponsored by the American Heart
Association (AHA) and ACC and published in 2015 (52),
uses the standard ACC recommendation classiﬁcation

T A B L E 3 Clinical Management of CAHAP With Established Cardiovascular Disease:

Essential Skills for the Sports Cardiologist
Medical Knowledge

Know the rationale and suggested use of the AHA/ACC Eligibility and Disqualiﬁcation
Recommendations for Competitive Athletes.
Know and understand an approach for determining eligibility for CAHAP with cardiovascular
diagnoses for which Class IIa and IIb eligibility recommendations have recently been
proposed.
Know current physical activity guidelines proposed for use in the general population with an
emphasis differentiating the role of exercise for health promotion versus athletic
performance.
Know common genetic and acquired forms of heart muscle disease that are associated with a risk
of adverse events during exercise.
Know contemporary guidelines for diagnosis, risk stratiﬁcation, and management of genetic and
acquired forms of heart muscle disease.
Know common genetic and acquired forms of electrical heart disease that are associated with
risk of adverse events during exercise.
Know contemporary guidelines for diagnosis, risk stratiﬁcation, and management of genetic and
acquired forms of electrical heart disease.

system and includes a large number of Class IIa and IIb

Know current indications for ICD implantation in the primary and secondary prevention settings.

recommendations with wording such as “may be

Know emerging data surrounding the safety of competitive sports eligibility among CAHAP with
conditions including but not limited to implantable cardiovascular devices and long QT
syndrome among CAHAP.

reasonable” or “may be considered,” providing sports
cardiologists and their patients an opportunity to
engage in shared decision making in situations with
uncertain risk and limited outcomes data. This
approach represents an important departure from
prior versions of this document, which gave a dichot-

Know epidemiological data establishing atherosclerotic coronary artery disease as a common
cause of exertional symptoms and cardiac arrest among CAHAP older than age 35 years.
Know the pros and cons of medical therapy versus revascularization among CAHAP with
atherosclerotic coronary artery disease.
Know the effect on exercise physiology and exercise safety of commonly prescribed medications
for the management of atherosclerotic coronary artery disease.

omous yes/no recommendation for sports eligibility.

Know the importance of hypertension as a causal factor in the development of cardiovascular
disease among CAHAP.

The following considerations have been developed to

Know the impact of antihypertensive agents on exercise physiology.

complement the eligibility recommendations by

Know the association between atrial arrhythmias and long-term exposure to endurance sporting
activity.

providing a disease management framework that
extends beyond the issue of competition eligibility.
DISEASES OF THE HEART MUSCLE. Hypertrophic

cardiomyopathy, the most common form of inherited
cardiomyopathy, was among the ﬁrst genetic heart
diseases linked with sudden death during exercise
(53). Diagnostic criteria and clinical management
strategies for CAHAP with cardiomyopathy, including
medication use, indications for implantable deﬁbrillator placement, and collaboration with a cardiomyopathy specialist, should not differ substantially from
those designed and routinely applied to more
sedentary members of the general population (54).
CAHAP with cardiomyopathy may be at increased
risk of malignant tachyarrhythmias and progression of
underlying disease. Recent data suggest that routine
vigorous exercise may increase the risks of congestive
heart failure and future arrhythmias among CAHAP
with arrhythmogenic RV cardiomyopathy, a form of
cardiomyopathy that can present across the age
spectrum (55). Recommendation statements thus
restrict vigorous exercise among those with diagnosed
or

even

probable/possible

arrhythmogenic

RV

dysplasia. For CAHAP with other cardiomyopathies,
the absolute risk of arrhythmia and disease progression remains poorly understood and difﬁcult to

Know how and when to opt for a rhythm versus a rate control strategy, including the use of
pharmacological and catheter-based sinus maintenance options, among CAHAP with atrial
arrhythmias.
Know the risk-beneﬁt proﬁles of various anticoagulation strategies (including the uses of aspirin,
warfarin, novel oral anticoagulants, and dual antiplatelet therapy) among CAHAP.
Patient Care and Procedural Skills

Skill to apply recommendations provided by the AHA/ACC Eligibility and Disqualiﬁcation
Recommendations for Competitive Athletes following diagnosis of deﬁnitive or suspected
cardiovascular disease.
Skill to implement shared decision-making strategies for eligibility decisions when risk of
participation is either uncertain or signiﬁcantly modiﬁable by medical, catheter-based, or
surgical therapy.
Skill to differentiate benign adaptive EICR from various forms of heart muscle disease that are
associated with risk of adverse events during exercise.
Skill to prescribe exercise designed to optimize long-term health among CAHAP disqualiﬁed
from competitive sports due to underlying structural or electrical heart disease.
Skills to assist with strategies to optimize safety of sport participation among CAHAP with
cardiovascular conditions, including but not limited to implantable cardiac devices and long
QT syndrome, who elect to participate in competitive and recreational sports.
Skills to direct clinical management of CAHAP with atherosclerotic coronary artery disease,
including recommendations regarding selection and duration of medications, decision making
regarding revascularization, and application of cardiac rehabilitation following acute
coronary syndromes.
Skills to diagnose hypertension at rest and during exercise.
Skills to implement lifestyle modiﬁcations and medical therapy for CAHAP with hypertension
that have minimal effects on exercise capacity and sport safety.
Skills to diagnose and manage, in partnership with an electrophysiologist, paroxysmal atrial
arrhythmias among CAHAP. This will include determination of rhythm versus rate control
strategies, selection and sequencing of medical and catheter based techniques, and
guideline-dictated use of anticoagulation with consideration of its effect on sport and
exercise safety.
ICD ¼ implantable cardiac deﬁbrillator; other abbreviations as in Table 1.

quantify, and consensus recommendations regarding
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sport participation are thus conservative. However,

risk of arrhythmia (59). However, recent observa-

relegation of CAHAP with cardiomyopathy to a

tional data describe no deaths in athletes among

sedentary lifestyle may have signiﬁcant adverse im-

competitive LQTS athletes who elect to continue

plications,

reduced

sport participation in conjunction with appropriate

emotional well-being (56). Sports cardiologists there-

disease-speciﬁc treatment (60). Current guidelines

fore play a critical role in the management of CAHAP

are therefore more permissive regarding sports

with cardiomyopathy by working to deﬁne and

among LQTS athletes by permitting consideration of

continually reﬁne a treatment strategy, including

continued participation after evaluation at special-

exercise recommendations that minimize risk while

ized centers and treatment, including the use of beta-

capitalizing on the health beneﬁts of routine low- to

blockers or surgical sympathetic denervation. In all

including

weight

gain

and

moderate-intensity exercise (57).
Myocarditis,

endorse unrestricted sport participation in athletes

muscle disease, is associated with increased risk of

with established LQTS, or alternative diagnoses with

arrhythmia during sport participation, and limited

similarly attendant risk, requires comprehensive

animal data suggest that exercise during the acute

shared decision making.

of

acquired

cases, the sports cardiologist’s recommendation to
heart

phases

an

myocarditis

inﬂammatory

cardiac

Wolf-Parkinson-White syndrome, as well as benign

dysfunction (58). Consequently, all athletic partici-

arrhythmias including re-entry mechanism supra-

pation should be restricted in the setting of suspected

ventricular arrhythmias (e.g., atrioventricular nodal

or conﬁrmed myocarditis. In most cases, myocarditis

supraventricular tachycardia), automaticity mediated

is a transient and self-limited condition, and full

supraventricular

resumption of exercise, following documentation of

cardia), and relatively benign idiopathic ventricular

disease

resolution

may

some

(e.g.,

atrial

tachy-

of

tachycardias (e.g., outﬂow tract tachycardias) are
common among CAHAP. These conditions may be

imaging, and ambulatory rhythm monitoring, is usu-

particularly amenable to catheter-based therapies

ally appropriate. The time course for resolution of

that offer a potential cure. It is the responsibility of

myocarditis and the prognostic implications of re-

the sports cardiologist, in conjunction with a CV

sidual

electrophysiologist, to ensure deﬁnitive diagnosis,

scarring

combination

arrhythmias

biochemical testing, exercise testing, noninvasive

myocardial

with

exacerbate

remain

incompletely

characterized. The majority of CAHAP will demon-

risk stratiﬁcation, and therapy. Evaluation may

strate complete resolution by 3 to 6 months, but

include maximal effort-limited exercise testing and

prolonged or recurrent symptoms and laboratory/

an invasive electrophysiology study that can be

imaging evidence of ongoing inﬂammation do occur

used to determine optimal management strategies,

and may prolong the time required for safe resump-

including observation, drug therapy, or catheter

tion of training and competition.

ablation (61). In most cases, effective treatment will

ELECTRICAL HEART DISEASE. Abnormalities of the

sufﬁciently reduce or eliminate risk to permit unre-

cardiac ion channels may increase the risk of malig-

stricted participation in competitive athletics.

sport

INTRACARDIAC DEVICE CONSIDERATIONS. CAHAP

participation. CAHAP with suspected or conﬁrmed

should receive an implantable cardiac-deﬁbrillator

channelopathy should be evaluated at specialized

(ICD) based on standard recommendations for pri-

centers that possess expertise in both genetic

mary and secondary prevention. ICD placement in

electrical heart disease and sports cardiology. This

CAHAP that do not meet routine ICD implantation

multidisciplinary

accurate

criteria simply to facilitate “safer” future sport

characterization of individual patient risk, custom-

participation is inappropriate. Historically, sport

ization of treatment that is adherent to current rec-

participation

ommendations, and effective counseling regarding

restricted based on hypothetical risks, including po-

longitudinal approaches to competitive athletics and

tential failure of the ICD to terminate an arrhythmia

recreational exercise. For CAHAP with channelopathy,

during exercise, injury or discomfort due to an

precautionary management steps include avoidance

appropriate shock, and damage to the ICD system,

of certain prescription and over the counter medica-

thereby rendering it ineffective. However, recent

tions; avoidance of dehydration, fever, and heat

prospective observational data suggest that young

stroke; and establishment of an emergency action

competitive athletes may be able to participate safely

plan emphasizing external deﬁbrillator access.

in competitive sports with minimal risk of life-

nant,

potentially

fatal

arrhythmia

approach

during

facilitates

Exercise among patients with LQTS, particularly
LQTS type 1, has been associated with an increased

among

CAHAP

with

an

ICD

was

threatening events, although ICD shocks did occur
during

exercise

(62,63).

Consequently,
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sports

in a formal cardiac rehabilitation program with close

participation among athletes with ICDs, which requires

oversight from a sports cardiologist, who can tailor an

a thoughtful, shared decision-making process involving

exercise regimen that may necessarily exceed in-

the patient, care providers, and other relevant stake

tensity levels commonly used in more sedentary

recommendations

permit

consideration

of

holders, including parents, coaches, athletic trainers,

patients.

and sport organization leadership. In cases where a

HYPERTENSION. Hypertension is common among

consensus decision is made that return to play is desir-

CAHAP

able and permissible, customized maximal effort exer-

CAHAP, by virtue of how healthy they appear, are

cise testing to evaluate for inducible arrhythmias, careful

underdiagnosed and undertreated. Bilateral brachial

individualized device programming, and development

artery blood pressures should be assessed in CAHAP

of a remote ICD monitoring plan should be conducted

at each clinical encounter, and blood pressure should

prior to participation.

be measured at least once in the leg to exclude

ATHEROSCLEROTIC CV DISEASE. Routine exercise

has favorable effects on traditional CV risk factors
and reduces incident ASCVD, but does not confer
complete

immunity.

community-based

Recent

survey

competitive

data

master

from

athletes

demonstrate a high prevalence of ASCVD risk factors
and indicate that ASCVD is among the most common
forms of acquired heart disease in this population
(64). In addition, autopsy and clinical data from
observational sudden death and cardiac arrest studies
routinely identify ASCVD as the most common cause
of sudden death in aging CAHAP (65). The pathophysiology of ASCVD in CAHAP remains incompletely
understood and constitutes an area of active investigation (66). ASCVD may be driven by traditional risk
factors or by less obvious mediators, including
macronutrient dietary choices, psychological stress,
and perhaps high volumes of exercise itself.
Management of CAHAP with ASCVD, including
those with stable disease and those who manifest
with acute coronary syndromes, should adhere to
consensus recommendations for the general population. Sports cardiologists may elect for more aggressive and complete revascularization strategies in
CAHAP than in sedentary patients based on data
documenting

asymptomatic

exertional

ischemia

caused by obstructive ASCVD as an important cause
of sudden death (2). CAHAP with ASCVD should be
prescribed high-dose statins and antiplatelet agents
as dictated by presentation and coronary anatomy.
Statin-related muscle side effects during exercise are
relatively frequent among CAHAP. However, statin
therapy following an acute coronary syndrome, even

in

clinical

practice.

Many

hypertensive

coarctation of the aorta. Diagnostic criteria and corollary management strategies proposed by the most
recent Joint National Committee document (68) are
appropriate for use in CAHAP with several caveats.
CAHAP with borderline blood pressure should be
encouraged to perform home monitoring, using a
commercial sphygmomanometer that has been calibrated against a professional grade aneroid cuff, to
deﬁnitively diagnose or exclude hypertension. Most
CAHAP meet or exceed levels of physical activity that
have been associated with reductions in systolic and
diastolic blood pressure (69), rendering escalation of
exercise volume of limited value. Pharmacotherapy
should

prioritize

converting

vasodilators

enzyme

(i.e.,

inhibitors,

angiotensin-

dihydropyridine

calcium-channel blockers) with minimal effect on
exercise physiology over drugs with negative chronotropic effects and diuretic agents, which may affect
chronotropic function and predispose to dehydration,
respectively. Maximal effort exercise testing is of
considerable value in the assessment of suspected
hypertension and the management of those with
established disease. Exaggerated exercise systolic
blood pressures are predictive of future hypertension
(70,71), and may indicate suboptimal medical therapy
in CAHAP taking antihypertensive drugs (72). It is,
however, important for the sports cardiologist to
recognize that blood pressure may reach extremely
high levels during high-intensity exercise training
and competition (73): transient peak systolic blood
pressures up to 250 mm Hg or even higher are expected and permissible in CAHAP without resting
hypertension and underlying CV disease.

if it requires reductions in exercise training and

ATRIAL FIBRILLATION. Atrial ﬁbrillation is the most

competition, should be prioritized for 1 to 2 years, as

common arrhythmia in the general population and

this initial period of drug exposure appears to have

may be even more prevalent among aging CAHAP. A

the greatest beneﬁt (67). The role for novel lipid-

compelling body of published data suggests that ag-

lowering agents in CAHAP who are intolerant of sta-

ing CAHAP, particularly those that engage in endur-

tins has not yet been deﬁned, but may be considered.

ance sports, are at increased risk for atrial ﬁbrillation

All CAHAP presenting with an acute coronary syn-

and ﬂutter compared with age- and sex-matched

drome should be strongly encouraged to participate

normally active people (74). As reviewed elsewhere,
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medications and ablation should be considered in the

T A B L E 4 PPCS: Essential Skills for the Sports Cardiologist

context of a shared decision making process, as there

Medical Knowledge

are inherent risks and beneﬁts to both approaches.

Know current AHA/ACA and other relevant professional organization recommendations for PPCS
practices.

Experience with catheter-based therapy for atrial

Know that there are insufﬁcient data to deﬁne the effect of PPCS on sudden cardiac death.
Know the rational and potential limitations of PPCS conﬁned to a focused medical history and
physical examination.
Know the importance of using tools to standardize medical history and physical examination
during PPCS.

ﬁbrillation continues to mount and appears to be
effective for many CAHAP. Current U.S. and European
guidelines (both Class IIa recommendations) allow for
ablation as an initial approach for rhythm control.

Know the controversial role of adjunct testing, including the use of ECG and noninvasive imaging
during PPCS.

Anticoagulation to reduce the risk of thromboembolic
disease should be considered in all CAHAP with atrial

Know the current variability in PPCS practices in the United States as dictated by competition
level, provider preferences, and local resources.

ﬁbrillation and ﬂutter (76). Many CAHAP have lone

Know the importance of establishing local resources in determining when and how to implement
a PPCS program.

risk proﬁles to avoid anticoagulation. Warfarin or a

Know how to identify and engage relevant stakeholders that play critical roles in the design and
implementation of PPCS programs.
Know potential roles of the sports cardiologist during the design, implementation, and
reﬁnement of PPCS programs.

atrial ﬁbrillation or sufﬁciently low thromboembolic
novel oral anticoagulant should be used based on algorithms proposed for use in the general population.
Athletes taking these agents should be counseled

Know how to identify clinical practice resources required to optimally support local, regional, or
national PPCS initiatives.
Know how to rapidly and effectively handle abnormal ﬁndings documented during PPCS.
Know how and when to partner with specialized sports cardiology centers during the evaluation
of CAHAP with abnormal ﬁndings documented during PPCS.

about the risks of bleeding in the setting of contact
sports or sports with an inherent risk of trauma such
as cycling or martial arts. Following catheter ablation,
anticoagulation should be continued for some period
of time, although data deﬁning the optimal duration

Patient Care and Procedural Skills

of therapy are lacking.

Skills to direct the planning of a new or revision of an established PPCS program.
Skills to identify key stakeholders, including but not limited to school administrators and athletic
directors, coaches, athletic trainers, team physicians, and parents, during the planning and
implementation of a PPCS program.
Skills to conduct and/or oversee all aspects of PPCS, including performance and documentation
of a focused medical history and physical examination, performance and interpretation of
ECG using contemporary athlete criteria, and direction of assessments for CAHAP deemed to
have abnormal ﬁndings during PPCS.
Skills to document the yield of a PPCS program, including characterization of both true and false
positive ﬁndings.
Skills to work in a team-based, collaborative approach during all aspects of the design,
implementation, and reﬁnement of a PPCS program.

PRE-PARTICIPATION CARDIOVASCULAR
SCREENING
RATIONALE FOR PPCS. Pre-participation screening

for occult CV disease is recommended by numerous
professional organizations. The rationale for PPCS is
that the detection of heart diseases associated with
risk for sudden death provides an opportunity to
reduced adverse events through disease-speciﬁc

PPCS ¼ pre-participation cardiovascular screening; other abbreviations as in Table 1.

therapy and/or sport restriction. Recently, a more
comprehensive rationale for PPCS that includes edu-

the pathogenesis of atrial ﬁbrillation in CAHAP is
complex, multifactorial, and incompletely understood (75), with casual mediators including atrial
remodeling, enhanced vagal nerve activity resulting
in

marked

resting

bradycardia,

inﬂammation,

exercise-induced surges in left atrial pressure, genetics, and alcohol consumption. The ﬁrst management step is to determine triggers for arrhythmia.
CAHAP that develop atrial arrhythmias during exercise may be managed using low doses of negative
chronotropic

agents,

including

beta-blockers

or

calcium-channel blockers, with little or no effect on

cation, substance abuse screening, detection of other
medical issues, and introduction to medical care
providers for young competitive athletes has been
proposed (77). It must be emphasized that data conﬁrming the efﬁcacy of PPCS as an effective strategy
for reducing the incidence of sport-related cardiac
arrest and sudden death are lacking. Contemporary
clinical practice guidelines and expert recommendations dictating PPCS practices are, therefore, based
largely on indirect evidence and expert opinion.
Essential knowledge base and skill sets for the sports
cardiologist to the PPCS are shown in Table 4.

exercise capacity. However, this approach may be

PPCS RECOMMENDATIONS. Current AHA/ACC rec-

ineffective and may actually increase arrhythmia

ommendations regarding PPCS endorse a strategy

burden among CAHAP that develop atrial arrhythmias

conﬁned to a focused medical history and physical

during sleep or at rest. The choice between rate con-

examination (78). This approach is justiﬁed by its

trol and rhythm control is generally clear in this

reliance on minimal care provider expertise and low

population, as atrial ﬁbrillation and ﬂutter are usually

cost,

poorly tolerated. In those that choose a rhythm

dissemination with minimal resource allocation.

control strategy, options including antiarrhythmic

Standardization of the medical history and physical

factors

expected

to

promote
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examination has been identiﬁed as a key aspect of

encouraged to partner with a sports cardiologist or

high-quality PPCS. The Pre-Participation Physical

sports cardiology program. The pre-implementation

Evaluation (PPE)-4, commonly referred to as the PPE

planning phase of PPCS should allow ample time for

Monograph, created in collaborative fashion by mul-

discussion aimed at determining the optimal local

tiple professional organizations and endorsed by the

strategy. Sports cardiologists who participate in PPCS

ACC and the AHA (79), was designed for this purpose.

should be: 1) versed in current professional society

The PPE-4 is a comprehensive guide to PPCS that

recommendations; 2) aware of areas of controversy

represents the current standard of care and should be

surrounding different strategies; 3) familiar with all

strongly considered for use by sports cardiologists

aspects of the school or sponsoring organization
including ﬁnancial and personnel resources; 4)

who engage in PPCS.
The efﬁcacy of PPCS conﬁned to medical history

collaborative with key stakeholders including team

and physical examination remains uncertain, but

physicians, athletic trainers, coaches, parent groups,

may be associated with low levels of sensitivity and

and athletic directors; and 5) capable of the evalua-

speciﬁcity for CV disease detection. This concern has

tion of athletes found to have abnormal ﬁndings.

led some organizations to recommend the inclusion

Sports cardiologists who support PPCS initiatives

of additional diagnostic testing, including the use of

must ensure that their clinical practice environment

ECG (18), based on its proposed ability to improve

is capable of handling a rapid inﬂux of patients

the overall accuracy of PPCS. As discussed in the

and supporting the downstream testing required

previous text, studies examining the performance of

following PPCS.

ECG during PPCS consistently demonstrate its ability
to detect more cases of occult disease than medical
history and physical examination, but also its propensity to increase the rate of false positive results.
Current U.S. recommendations discourage mandatory widespread ECG-inclusive screening for athletes
and nonathletic youthful populations citing concerns
about the ﬁnancial and medical consequences of
this approach. However, current U.S. recommendations
cautiously acknowledge the potential beneﬁt of ECGinclusive PPCS in local settings with the necessary
ﬁnancial resources and clinical infrastructure.
Although several professional sporting organizations, including the National Basketball Association
and the Federation Internationale de Football Association, utilize PPCS protocols inclusive of transthoracic echocardiography, this approach has not
been endorsed by most professional medical organizations. Some groups that perform ECG-inclusive
PPCS provide on-site echocardiography with use
limited to the evaluation of CAHAP with ECGs sug-

ADDITIONAL CONSIDERATIONS
PEDIATRIC CAHAP. Adolescent and young adults

represent a signiﬁcant segment of the CAHAP population. Differentiation of EICR from pathology among
pediatric CAHAP is complicated by factors including
rapid growth and development of the heart and blood
vessels, conventional reliance on body surface area–
indexed measurements, and incompletely developed
motor coordination and/or ability to follow the relatively complex directions required for advanced exercise and imaging testing. Management of pediatric
CAHAP requires expertise in navigating the triangular
relationship between the physician, the patient, and
the parents with consideration of guardianship, legal
responsibility, and informed consent. Sports cardiologists not trained in pediatrics should collaborate
with pediatric CV medicine providers during the care
of all young CAHAP that have not completed physiological maturation.

gestive of structural heart disease (80). However, it

MEDICAL LEGAL CONSIDERATIONS. Sports cardiol-

must be emphasized that performance and interpre-

ogists considering the eligibility of an athlete with CV

tation of echocardiography requires considerable

disease should consider the relevant legal issues (82).

echocardiography

Current guidelines state that “a physician’s general

should be performed only in settings with adequate

legal duty is to conform to accepted, customary, or

quality control.

reasonable medical practice providing sports partici-

clinical

expertise,

and

onsite

pation recommendations consistent with an athlete’s
ROLE OF THE SPORTS CARDIOLOGIST IN PPCS. Sports

medical best interests” (83). Several relevant court

cardiologists may play an invaluable role in the PPCS

cases have addressed the complexity of this issue

process and should be involved in its planning,

with varying legal rulings, including the support of a

implementation, and reﬁnement. Sporting organiza-

university’s right to exclude a student athlete from

tions’ ofﬁcial team physicians, the individuals ulti-

participation (Knapp v Northwestern) and the sup-

mately responsible for determining sport eligibility

port of a professional athlete’s right to make an

among CAHAP with CV disease (81), are strongly

informed

decision

(Mobley

v

Madison

Square
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Garden). For schools and professional teams that

banned substances is a major problem in contempo-

choose to allow an athlete to make an informed de-

rary organized athletics (85). Sports cardiologists

cision, many issues remain unknown including best

should develop a familiarity with banned substances

documentation practices and the role of legal

including anabolic steroids, stimulants, and red

waivers. Recent changes in the AHA/ACC eligibility

cell–boosting agents (86,87), and should routinely

recommendations (53) from dichotomous yes/no

question patients about their use and counsel them

recommendations to less deﬁnitive approaches, in

about health risks and uncertain safety proﬁles.

which sport participation may be “reasonable” or

Banned

“considered,” opens new legal questions regarding an

international governing bodies include commonly

athlete’s right to return to play that have yet to be

prescribed medications, such as beta-adrenergic

tested in a rigorous legal framework.

blockers, beta-adrenergic agonists, glucocorticoids,

PUBLIC POLICY RELATED TO THE SAFETY OF SPORTS

diuretic agents, and pharmaceutical grade stimulants

AND EXERCISE. The sports cardiology community

substance

lists

developed

by

national/

including methylphenidate. When use of these agents

must remain committed to working with state legis-

is deemed a medical necessity and appropriate alter-

lators and community leaders to formulate policies

natives are lacking, therapeutic use exemptions may

dedicated to the health and safety of CAHAP.

be obtained. Sports cardiologists should familiarize

The ACC’s Sports and Exercise Cardiology Council, the

themselves with this process.

AHA, and other medical societies have authored
clinical documents and recommendations to guide
lawmakers and stakeholders in developing public
policies aimed at improving athlete safety and
reducing sudden cardiac arrest (83,84). Legislators are
increasingly interested in PPCS and laws stipulating
speciﬁc approaches to PPCS have been implemented.
Sports cardiologists are urged to remain apprised of
such initiatives, to play an active role in their planning
and dissemination, and to educate legislators that
no PPCS approach will eliminate exercise-related
sudden cardiac arrest. Comprehensive emergency action planning focusing on access to timely bystander
cardiopulmonary resuscitation and early deﬁbrillation
is required to ensure efﬁcient and structured response
to sudden cardiac arrest. Sports cardiologists are
encouraged to work with organizations that sponsor,
house, or oversee competitive sports and organized
exercise programs to develop, rehearse, and reﬁne
emergency action plans that are speciﬁc to the athletic
venue and type of exercise performed.

FUTURE DIRECTIONS
The emerging ﬁeld of sports cardiology is in rapid
evolution. Optimal care of CAHAP requires the integration of fundamental general cardiology principles
with the unique knowledge base and skillset that are
speciﬁc to this patient population. As the number of
practicing sports cardiologists continues to rise, it is
of paramount importance that high-quality standards
of clinical care and targeted research initiatives
continue to develop in parallel. Future efforts to
ensure the provision of effective sports cardiology
care must include educational initiatives geared toward CV trainees and established CV practitioners. In
parallel, the scientiﬁc community must assume responsibility for the oversight of outcomes-based
research designed to address the many remaining
areas of uncertainty.
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